Cargando…

The natural history of a delayed detectable PSA after radical prostatectomy

INTRODUCTION: Men with a detectable PSA after radical prostatectomy (RP) are often offered salvage therapy while those with an undetectable PSA are monitored. We aim to better characterize the natural history of men with an initially undetectable PSA who subsequently developed a detectable PSA > ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szymaniak, Julie A., Washington, Samuel L., Cowan, Janet E., Cooperberg, Matthew R., Lonergan, Peter E., Nguyen, Hao G., Meng, Maxwell V., Carroll, Peter R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638081/ https://www.ncbi.nlm.nih.gov/pubmed/36765111 http://dx.doi.org/10.1038/s41391-022-00638-y

Ejemplares similares

Observation, Radiotherapy, or Radical Prostatectomy for Localized Prostate Cancer: Survival Analysis in the United States
por: Han, Jang Hee, et al.
Publicado: (2023)

Active surveillance in intermediate-risk prostate cancer with PSA 10–20 ng/mL: pathological outcome analysis of a population-level database
por: Lonergan, Peter E., et al.
Publicado: (2021)

Ten‐year work burden after prostate cancer treatment
por: Washington, Samuel L., et al.
Publicado: (2023)

Prognostic significance of a novel indicator (PSA(postd3)/PSA(pre)) for PSA recurrence in patients after radical prostatectomy
por: Zhou, Zhien, et al.
Publicado: (2019)

Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival
por: Doherty, A P, et al.
Publicado: (2000)

PSA mass as a marker of prostate cancer progression after radical prostatectomy
por: Bryniarski, Piotr, et al.
Publicado: (2011)

Heterophilic Antibodies Resulting in False Positive Elevation of PSA After Radical Prostatectomy
por: Asha, Wafa, et al.
Publicado: (2023)

Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US
por: Washington, Samuel L., et al.
Publicado: (2020)

Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience
por: Quero, Laurent, et al.
Publicado: (2008)

Comparison of Pathological and Biochemical Outcomes after Radical Prostatectomy in Korean Patients with Serum PSA Ranges
por: Lee, Hye Won, et al.
Publicado: (2015)

Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA >20 ng/mL
por: Hinev, Alexander I., et al.
Publicado: (2012)

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy
por: Zabalza, Cristina Villares, et al.
Publicado: (2015)

Evaluating the Impact of PSA as a Selection Criteria for Nerve Sparing Radical Prostatectomy in a Screened Cohort
por: Tanguturi, Shyam K., et al.
Publicado: (2014)

[−2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report
por: De Luca, S., et al.
Publicado: (2016)

(68)Ga-PSMA PET/CT versus CT and bone scan for investigation of PSA failure post radical prostatectomy
por: Yuminaga, Yuigi, et al.
Publicado: (2021)

Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death
por: Tilki, Derya, et al.
Publicado: (2023)

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy()
por: Minner, Sarah, et al.
Publicado: (2019)

(68)Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy
por: von Eyben, Finn Edler, et al.
Publicado: (2021)

Explainable ML models for a deeper insight on treatment decision for localized prostate cancer
por: Han, Jang Hee, et al.
Publicado: (2023)

Lack of an Association between Neutrophil-to-Lymphocyte Ratio and PSA Failure of Prostate Cancer Patients Who Underwent Radical Prostatectomy
por: Maeda, Yoko, et al.
Publicado: (2016)

Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy
por: Ahn, Hyun Kyu, et al.
Publicado: (2020)

What is the possible role of PSA doubling time (PSADT) and PSA velocity (PSAV) in the decision-making process to initiate salvage radiotherapy following radical prostatectomy in patients with prostate cancer?
por: Milecki, Piotr, et al.
Publicado: (2011)

Quantifying the natural history of post-radical prostatectomy incontinence using objective pad test data
por: Smither, Anna R, et al.
Publicado: (2007)

Salvage robotic radical prostatectomy
por: Kaffenberger, Samuel D., et al.
Publicado: (2014)

Reduction in PSA messenger-RNA expression and clinical recurrence in patients with prostatic cancer undergoing neoadjuvant therapy before radical prostatectomy
por: Grasso, Marco, et al.
Publicado: (2004)

Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time
por: Andersen, Sigve, et al.
Publicado: (2014)

Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy
por: Wang, Yu-Jen, et al.
Publicado: (2016)

Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy
por: Cheng, Yung-Ting, et al.
Publicado: (2020)

Establishment and Validation of a Novel Prediction Model for Early Natural Biochemical Recurrence After Radical Prostatectomy Based on Post-Operative PSA at Sixth Week
por: Lian, Bijun, et al.
Publicado: (2023)

Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy
por: Kelkar, Sonia, et al.
Publicado: (2021)

Disease Control With Delayed Salvage Radiotherapy for Macroscopic Local Recurrence Following Radical Prostatectomy
por: Shelan, Mohamed, et al.
Publicado: (2019)

Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens
por: de Lima, Nelson Gianni, et al.
Publicado: (2013)

Exploring Prostate Cancer Genome Reveals Simultaneous Losses of PTEN, FAS and PAPSS2 in Patients with PSA Recurrence after Radical Prostatectomy
por: Ibeawuchi, Chinyere, et al.
Publicado: (2015)

Changes of Radiation Treatment Concept Based on (68)Ga-PSMA-11-PET/CT in Early PSA-Recurrences After Radical Prostatectomy
por: Bottke, Dirk, et al.
Publicado: (2021)

False Positive Findings of [(18)F]PSMA-1007 PET/CT in Patients After Radical Prostatectomy with Undetectable Serum PSA Levels
por: Orevi, Marina, et al.
Publicado: (2022)

Complete PSA Remission without Adjuvant Therapy after Secondary Lymph Node Surgery in Selected Patients with Biochemical Relapse after Radical Prostatectomy and Pelvic Lymph Node Dissection
por: Winter, Alexander, et al.
Publicado: (2012)

Contemporary Radical Prostatectomy
por: Fu, Qiang, et al.
Publicado: (2011)

Laparoscopic radical prostatectomy
por: Lipke, Michael, et al.
Publicado: (2005)

Comparative effectiveness of robotic and open radical prostatectomy
por: Pessoa, Rodrigo Rodrigues, et al.
Publicado: (2021)

Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy in a National Veterans Affairs Cohort
por: Vaculik, Kristina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_02q2mel83tao95cqv5r9t01f6l